Patents by Inventor Kathy Chiu

Kathy Chiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYNUCLEOTIDES FOR AMPLIFICATION AND DETECTION OF SARS-COV-2
    Publication number: 20210340622
    Abstract: Disclosed herein are primers and probes related to the detection of SARS-CoV-2 via nucleic acid amplification testing (NAAT), for example to amplify and determine the presence of SARS-CoV-2 in test samples and/or to diagnose Covid-19. Specifically, the present disclosure describes primers and probes that bind to the N gene, ORF1ab, or E gene of SARS-CoV-2 coronavirus for detection via loop mediated isothermal amplification (LAMP) and molecular beacon hybridization.
    Type: Application
    Filed: May 20, 2021
    Publication date: November 4, 2021
    Inventors: Nadya Andini, Kathy Chiu, Xuewen Jiang, Hédia Maamar
  • POLYNUCLEOTIDES FOR AMPLIFICATION AND DETECTION OF SARS-COV-2
    Publication number: 20210292854
    Abstract: Disclosed herein are primers and probes related to the detection of SARS-CoV-2 via nucleic acid amplification testing (NAAT), for example to amplify and determine the presence of SARS-CoV-2 in test samples and/or to diagnose Covid-19. Specifically, the present disclosure describes primers and probes that bind to the N gene, ORF1ab, or E gene of SARS-CoV-2 coronavirus for detection via loop mediated isothermal amplification (LAMP) and molecular beacon hybridization.
    Type: Application
    Filed: June 25, 2020
    Publication date: September 23, 2021
    Inventors: Nadya Andini, Kathy Chiu, Xuewen Jiang, Hédia Maamar
  • Polynucleotides for amplification and detection of SARS-CoV-2
    Patent number: 11047007
    Abstract: Disclosed herein are primers and probes related to the detection of SARS-CoV-2 via nucleic acid amplification testing (NAAT), for example to amplify and determine the presence of SARS-CoV-2 in test samples and/or to diagnose Covid-19. Specifically, the present disclosure describes primers and probes that bind to the N gene, ORF1ab, or E gene of SARS-CoV-2 coronavirus for detection via loop mediated isothermal amplification (LAMP) and molecular beacon hybridization.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: June 29, 2021
    Assignee: Talis Biomedical Corporation
    Inventors: Nadya Andini, Kathy Chiu, Xuewen Jiang, Hédia Maamar